InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the full record of transactions filed by Yorke Justin W, Director. Officer active across 1 companies, notably Processa Pharmaceuticals, Inc.. Cumulatively, 9 disclosures have been published. Total volume traded: €58k. The latest transaction was filed on 27 January 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations9 total
4,393 shares
Common Stock
SEC:0001567619-22-008006:0·
€5,4421,854 shares@ €2.9350.083% mcap18.8% of flow
Common Stock
SEC:0001567619-22-002079·
€5,4421,854 shares@ €2.9350.083% mcap9.4% of flow
Common Stock
SEC:0001567619-22-002079:0·
€23,5265,500 shares@ €4.27750.36% mcap81.2% of flow
Common Stock
SEC:0001567619-21-021710·
€23,5265,500 shares@ €4.27750.36% mcap40.6% of flow
Common Stock
SEC:0001567619-21-021710:0·
1,169 shares
Common Stock
SEC:0001567619-21-016570·
1,169 shares
Common Stock
SEC:0001567619-21-016570:0·
1,169 shares
Common Stock
SEC:0001567619-21-014756·
1,169 shares
Common Stock
SEC:0001567619-21-014756:0·
9 of 9 declarations
About Yorke Justin W
Justin W. Yorke serves as a Director of Processa Pharmaceuticals, Inc. He provides strategic expertise to the board of directors, contributing to governance and key decision-making for the company. His experience in the pharmaceutical sector is an asset to the organization.
